MK-4305-006

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-4305-006, covering 2014-11-14 to 2014-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006) [Phase 2]